@article{gieger_rassnick_siegel_proulx_bergman_anderson_ladue_smith_northrup_roberts_2008, title={Palliation of clinical signs in 48 dogs with nasal carcinomas treated with coarse-fraction radiation therapy}, volume={44}, ISSN={["1547-3317"]}, DOI={10.5326/0440116}, abstractNote={Data from 48 dogs with nasal carcinomas treated with palliative radiation therapy (PRT) were retrospectively reviewed. Factors potentially influencing resolution of clinical signs and survival after PRT were evaluated. Clinical signs completely resolved in 66% of dogs for a median of 120 days. The overall median survival time was 146 days. Duration of response to PRT was shorter in dogs that had clinical signs for <90 days before PRT. Survival times were shorter in dogs that had partial or no resolution of clinical signs after PRT than in dogs that had complete resolution of clinical signs.}, number={3}, journal={JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION}, author={Gieger, Tracy and Rassnick, Kenneth and Siegel, Sheri and Proulx, David and Bergman, Philip and Anderson, Christine and LaDue, Tracy and Smith, Annette and Northrup, Nicole and Roberts, Royce}, year={2008}, pages={116–123} }
 @article{looper_malarkey_ruslander_proulx_thrall_2006, title={Epidermal growth factor receptor expression in feline oral squamous cell carcinomas}, volume={4}, ISSN={["1476-5829"]}, DOI={10.1111/j.1476-5810.2006.00091.x}, abstractNote={Feline oral squamous cell carcinomas (SCC) have a poor prognosis despite aggressive treatment with surgery, radiation and anticancer drugs. Overexpression of the epidermal growth factor receptor (EGFR), a membrane-bound tyrosine kinase receptor, has been found in many human epithelial neoplasms, including oral SCC. EGFR overexpression has been associated with advanced disease and a poor prognosis. The purpose of this study was to determine whether feline oral SCC express EGFR. Thirteen formalin-fixed paraffin wax-embedded biopsy samples from feline oral SCC were analysed for EGFR expression using immunohistochemistry. Nine of 13 tumours (69%) were positive for EGFR expression, suggesting that altered EGFR expression plays a role in feline oral SCC and provides a rationale for a potential clinical benefit using EGFR inhibitors in combination with conventional treatments.}, number={1}, journal={VETERINARY AND COMPARATIVE ONCOLOGY}, author={Looper, J. S. and Malarkey, D. E. and Ruslander, D. and Proulx, D. and Thrall, D. E.}, year={2006}, month={Mar}, pages={33–40} }
 @article{rassnick_goldkamp_erb_scrivani_njaa_gieger_turek_mcniel_proulx_chun_et al._2006, title={Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003)}, volume={229}, ISSN={["0003-1488"]}, DOI={10.2460/javma.229.3.401}, abstractNote={To evaluate factors associated with survival in dogs with nasal carcinomas that did not receive treatment or received only palliative treatment.Retrospective case series.139 dogs with histologically confirmed nasal carcinomas.Medical records, computed tomography images, and biopsy specimens of nasal carcinomas were reviewed. Only dogs that were not treated with radiation, surgery, chemotherapy, or immunotherapy and that survived > or = 7 days from the date of diagnosis were included. The Kaplan-Meier method was used to estimate survival time. Factors potentially associated with survival were compared by use of log-rank and Wilcoxon rank sum tests. Multivariable survival analysis was performed by use of the Cox proportional hazards regression model.Overall median survival time was 95 days (95% confidence interval [CI], 73 to 113 days; range, 7 to 1,114 days). In dogs with epistaxis, the hazard of dying was 2.3 times that of dogs that did not have epistaxis. Median survival time of 107 dogs with epistaxis was 88 days (95% CI, 65 to 106 days) and that of 32 dogs without epistaxis was 224 days (95% CI, 54 to 467 days).The prognosis of dogs with untreated nasal carcinomas is poor. Treatment strategies to improve outcome should be pursued.}, number={3}, journal={JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION}, author={Rassnick, Kenneth M. and Goldkamp, Carrie E. and Erb, Hollis N. and Scrivani, Peter V. and Njaa, Bradley L. and Gieger, Tracy L. and Turek, Michelle M. and McNiel, Elizabeth A. and Proulx, David R. and Chun, Ruthanne and et al.}, year={2006}, month={Aug}, pages={401–406} }
 @article{hawkins_grooters_cowgill_proulx_davainis_ruslander_grindem_2006, title={Treatment of Conidiobolus sp pneumonia with itraconazole in a dog receiving immunosuppressive therapy}, volume={20}, DOI={10.1111/j.1939-1676.2006.tb00769.x}, number={6}, journal={Journal of Veterinary Internal Medicine}, author={Hawkins, Eleanor and Grooters, A. M. and Cowgill, E. S. and Proulx, D. R. and Davainis, G. M. and Ruslander, D. M. and Grindem, C. B.}, year={2006}, pages={1479–1482} }
 @article{proulx_ruslander_dodge_hauck_williams_horn_price_thrall_2003, title={A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation}, volume={44}, ISSN={["1058-8183"]}, DOI={10.1111/j.1740-8261.2003.tb00468.x}, abstractNote={Despite the early notion that canine oral malignant melanoma is radioresistant, recent data suggest that external beam radiotherapy is effective in local tumor control. However, optimal fractionation schedules have not been established. The high rate of regional and distant metastasis is another problem that has hindered long-term control. The role of chemotherapy in the management of canine oral melanoma has also not been determined. In this study, data from 140 dogs irradiated at North Carolina State University were evaluated with the following objectives: (1) to compare the efficacy of three radiation therapy protocols (36 Gy, 9 Gy x 4 fractions; 30 Gy, 10 Gy x 3 fractions; or >45 Gy, 2-4 Gy x 12-19 fractions) for the treatment of dogs with oral malignant melanoma, (2) to identify any host or tumor factors influencing prognosis, and (3) to determine the impact of systemic chemotherapy on treatment outcome. Information regarding response to therapy, disease progression, and survival were determined from the medical records or from information obtained by telephone or mail survey. Relationships between host, tumor, and treatment variables and outcome measures (response, time to first event, and survival) were evaluated using Fisher's exact test (response) and the Cox regression model (time to first event and survival). The median time to first event for the 140 dogs was 5.0 months (95% C.I., 4-6 months) and the median survival was 7.0 months (95% C.I., 6-9 months). In the univariate analysis, the following variables were associated with increased time to first event and survival: (1) rostral tumor sublocation; (2) lack of bone lysis observed on skull imaging, and (3) microscopic tumor burden. In a multivariate analysis of 111 dogs with complete data for these variables, tumor sublocation, bone lysis, and tumor volume were identified as joint predictors of time to first event (p < .001, p < .001, and p = .04, respectively) and survival (p < .001, p < .001, and p = .05, respectively). There were no differences in response, time to first event and survival between the three radiation therapy protocols used. Systemic chemotherapy had no impact on the development of metastatic disease, time to first event, or survival, although the dosages used in this study were suboptimal. External beam radiation therapy is effective in local disease control of canine oral malignant melanoma; however, the optimal fractionation scheme has yet to be determined. The high metastatic rate observed with this disease and the inefficacy of systemic chemotherapy indicate that further investigation into novel therapies is warranted.}, number={3}, journal={VETERINARY RADIOLOGY & ULTRASOUND}, author={Proulx, DR and Ruslander, DM and Dodge, RK and Hauck, ML and Williams, LE and Horn, B and Price, GS and Thrall, DE}, year={2003}, pages={352–359} }
 @article{hahn_proulx_muruthi_alberts_altmann_2003, title={Gastrointestinal parasites in free-ranging Kenyan baboons (Papio cynocephalus and P-anubis)}, volume={24}, ISSN={["0164-0291"]}, DOI={10.1023/A:1023092915171}, number={2}, journal={INTERNATIONAL JOURNAL OF PRIMATOLOGY}, author={Hahn, NE and Proulx, D and Muruthi, PM and Alberts, S and Altmann, J}, year={2003}, month={Apr}, pages={271–279} }
 @article{michau_proulx_rushton_olivry_dunston_gilger_davidson_2003, title={Intraocular extramedullary plasmacytoma in a cat}, volume={6}, ISSN={["1463-5224"]}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-0037629973&partnerID=MN8TOARS}, DOI={10.1046/j.1463-5224.2003.00277.x}, abstractNote={An 8-year-old, castrated male Domestic Short-haired cat was referred for evaluation of a possible intraocular neoplasm following previous ocular trauma. The eye was blind, and uveitis and an iridal mass were noted on examination. An enucleation was performed and the mandibular lymph node excised. Histopathologic examination revealed neoplastic proliferation of plasma cells in the iris and lymph node. No other evidence of disseminated disease was detected. This is the first case reported of an intraocular extramedullary plasmacytoma in the cat. The variation in clinical manifestations and potential association with multiple myeloma are not known at this time. Disseminated metastasis from a primary plasmacytoma of the uveal tract could also involve the bone marrow and be indistinguishable from multiple myeloma. Early enucleation, as in trauma-associated sarcomas, may be indicated to prevent metastasis. Periodic systemic evaluation for evidence of multiple myeloma should be performed.}, number={2}, journal={VETERINARY OPHTHALMOLOGY}, author={Michau, TM and Proulx, DR and Rushton, SD and Olivry, T and Dunston, SM and Gilger, BC and Davidson, MG}, year={2003}, month={Jun}, pages={177–181} }